- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x JBR: 4-[(3-carboxy-2-oxidanyl-naphthalen-1-yl)methyl]-3-oxidanyl-naphthalene-2-carboxylic acid(Non-covalent)
JBR.2: 12 residues within 4Å:- Chain A: A.113, F.114, W.117, P.123, R.125, P.152, P.153, H.154, R.171, R.175, Y.201
- Ligands: NAP.1
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:W.117, A:W.117, A:P.123, A:P.153, A:H.154
- Hydrogen bonds: A:W.117
- Salt bridges: A:R.125, A:H.154, A:R.171, A:R.175
- pi-Stacking: A:F.114
JBR.5: 14 residues within 4Å:- Chain A: T.86, S.89, R.93, R.135, K.138, V.139
- Chain B: Q.15, R.79, S.112, F.114, L.126, H.133, H.154
- Ligands: NAP.4
17 PLIP interactions:8 interactions with chain A, 9 interactions with chain B- Hydrophobic interactions: A:T.86, A:V.139, B:F.114, B:L.126
- Water bridges: A:R.135, A:K.138, A:V.139, B:Q.15, B:R.79, B:H.154
- Salt bridges: A:R.135, A:K.138, B:R.79, B:H.154
- pi-Cation interactions: A:R.93
- Hydrogen bonds: B:Q.15, B:R.79
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 3 residues within 4Å:- Chain A: S.174, R.175, V.176
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.175, A:V.176
SO4.6: 7 residues within 4Å:- Chain A: K.138, R.141
- Chain B: H.154, G.156, D.157, Q.158, V.176
7 PLIP interactions:3 interactions with chain A, 4 interactions with chain B- Water bridges: A:I.134, A:K.138
- Salt bridges: A:R.141, B:H.154
- Hydrogen bonds: B:D.157, B:Q.158, B:Q.158
SO4.7: 4 residues within 4Å:- Chain B: V.4, A.27, G.28, Y.29
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:A.27
- Water bridges: B:Y.29
SO4.8: 2 residues within 4Å:- Chain B: A.3, K.5
2 PLIP interactions:2 interactions with chain B- Water bridges: B:K.5
- Salt bridges: B:K.5
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kim, M. et al., Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX beta Reductase B as a Novel Thrombocytopenia Therapeutic Target. J.Med.Chem. (2022)
- Release Date
- 2022-01-19
- Peptides
- Flavin reductase (NADPH): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x JBR: 4-[(3-carboxy-2-oxidanyl-naphthalen-1-yl)methyl]-3-oxidanyl-naphthalene-2-carboxylic acid(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kim, M. et al., Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX beta Reductase B as a Novel Thrombocytopenia Therapeutic Target. J.Med.Chem. (2022)
- Release Date
- 2022-01-19
- Peptides
- Flavin reductase (NADPH): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D